EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer

Aldo Caltavituro, Antonio Giordano, Carmine De Angelis, Roberto Buonaiuto, Jacopo Canzian, Martí Torres-Marcén, Francesco Schettini, Giampaolo Bianchini, Beatrice Taurelli Salimbeni, Mario Giuliano, Grazia Arpino, Luca Malorni und 2 weitere

European Journal of Cancer · 2026-12 · 249 · 117794

DOI: 10.1016/j.ejca.2026.117794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2026-12. Verfasst von Aldo Caltavituro und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Translational Genomics and Targeted Therapies in Solid Tumors…. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Government Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerCDK4/6 inhibitorsCirculating tumor DNAESR1 mutationEndocrine resistanceEstrogen receptorPI3K/AKT/mTOR pathway

Autor:innen und Institutionen

  • Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Translational Genomics and Targeted Therapies in Solid Tumors, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS),…
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy; Breast Cancer T…
  • Breast Medical Oncology Unit, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcinai 4, Pieve Emanuele, Milan, 20072, Italy.
  • Translational Genomics and Targeted Therapies in Solid Tumors, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Förderung

  • Italian Government Ministry of Health

Zitieren

APA

Caltavituro, A., Giordano, A., De Angelis, C., Buonaiuto, R., Canzian, J., Torres-Marcén, M., Schettini, F., Bianchini, G., Salimbeni, B. T., Giuliano, M., Arpino, G., Malorni, L., De Laurentiis, M., & Criscitiello, C. (2026). Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer. European Journal of Cancer, 249, 117794. https://doi.org/10.1016/j.ejca.2026.117794

Vancouver

Caltavituro A, Giordano A, De Angelis C, Buonaiuto R, Canzian J, Torres-Marcén M, et al. Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer. European Journal of Cancer. 2026;249:117794. doi:10.1016/j.ejca.2026.117794

BibTeX
@article{Caltavituro2026,
  author = {Caltavituro, Aldo and Giordano, Antonio and De Angelis, Carmine and Buonaiuto, Roberto and Canzian, Jacopo and Torres-Marcén, Martí and Schettini, Francesco and Bianchini, Giampaolo and Salimbeni, Beatrice Taurelli and Giuliano, Mario and Arpino, Grazia and Malorni, Luca and De Laurentiis, Michelino and Criscitiello, Carmen},
  title = {Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {249},
  pages = {117794},
  doi = {10.1016/j.ejca.2026.117794}
}
Kostenlos starten →